Search details
1.
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
J Pathol
; 250(1): 19-29, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31471895
2.
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells.
Mol Ther Methods Clin Dev
; 23: 241-253, 2021 Dec 10.
Article
in English
| MEDLINE | ID: mdl-34703845
3.
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study.
Cell Death Dis
; 10(7): 534, 2019 07 11.
Article
in English
| MEDLINE | ID: mdl-31296838
Results
1 -
3
de 3
1
Next >
>>